A Closer Look at 10 Analyst Recommendations For Axsome Therapeutics
A Closer Look at 10 Analyst Recommendations For Axsome Therapeutics
对axsome therapeutics的10位分析师推荐进行更详细的分析
Analyzing Analyst Ratings: A Detailed...10 analysts have shared their evaluations of Axsome Therapeutics (NASDAQ:AXSM) during the recent three months, expressing a mix of bullish and bearish perspectives.
在过去的三个月中，有10位分析师分享了他们对axsome therapeutics（纳斯达克: AXSM）的评价，表达了看好和看淡的不同观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
In the assessment of 12-month price targets, analysts unveil insights for Axsome Therapeutics, presenting an average target of $131.9, a high estimate of $180.00, and a low estimate of $107.00. This upward trend is evident, with the current average reflecting a 0.77% increase from the previous average price target of $130.89.
在对axsome therapeutics的12个月目标价格进行评估时，分析师揭示了一些见解，提出了一个平均目标为131.9美元，一个高估值为180.00美元，一个低估值为107.00美元。这种上升趋势是显而易见的，当前平均目标反映了与上一个130.89美元平均目标相比的0.77%的增长。
Analyzing Analyst Ratings: A Detailed...
分析分析师...
登录免费看全文
登录/注册
资讯热榜
更新时间